Are electronic signatures legally binding?

Yes. Electronic signatures are legally recognized under the ESIGN Act (15 U.S.C. §7001) and by UETA in most states when intent, consent, attribution, and record retention are present.

When is a consumer disclosure required?

Consumer-facing records require ESIGN disclosures per 15 U.S.C. §7001(c): disclose the right to paper, confirm accessibility, and explain how to withdraw consent.

Do I need notarization for portfolio approvals?

Not usually for marketing approvals; notarization is only necessary when a state or specific contract requires it or when a document serves as an acknowledged legal instrument.

How long must I keep signed portfolio records?

Retention depends on applicable rules: IRS records three years (IRC §6501(a)), HIPAA six years (45 CFR §164.530(j)), or longer per state law or industry regulation.

What if an approver changes their name or role?

Maintain historical approvals with recorded name, title, and date. If identity differs, include verifying documentation to preserve attribution and mitigate disputes.

How should I handle PHI in marketing materials?

Avoid using PHI in marketing. If PHI is present, ensure HIPAA-compliant handling, a Business Associate Agreement, and appropriate patient authorization per HIPAA rules.

Electronic Signature
Templates
Marketing
Marketing Publication Portfolio

Marketing Publication Portfolio

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

MARKETING PUBLICATION PORTFOLIO

This Marketing Publication Portfolio Agreement (the "Agreement") is entered into by and between Brand/Client: and Agency/Creator: effective as of .

PARTIES AND CONTACTS

Brand / Client — Legal Entity Brand / Client — Address & Contact Agency / Creator — Legal Entity Agency / Creator — Address & Contact

CAMPAIGN OVERVIEW

Campaign Name Objectives Target Audience Primary Channels (check all that apply)

Social media Print Online publications Email Events Other:

PORTFOLIO — PUBLICATIONS & PLACEMENTS

List prior or proposed publications intended for inclusion in the Portfolio. Parties may reference attachments for additional items. Each entry below constitutes a listed Publication Item and is represented by the Agency/Creator as accurate and free of third-party encumbrances subject to the Representations and Warranties section.

Publication Item 1 — Title / Headline Publication Name / Outlet

Publication Date:

Circulation / Estimated Reach Format / Asset Type Publication Item 2 — Title / Headline Publication Name / Outlet

Publication Date:

Circulation / Estimated Reach Format / Asset Type Publication Item 3 — Title / Headline Publication Name / Outlet

Publication Date:

Circulation / Estimated Reach Format / Asset Type

DELIVERABLES & SCHEDULE

Specify deliverables to be provided, required formats, and deadlines. Deliverables listed below are incorporated into this Agreement and shall be considered material obligations of the Agency/Creator.

Deliverable 1 — Description Deliverable 1 — Format & Quantity

Deliverable 1 Deadline:

Deliverable 2 — Description Deliverable 2 — Format & Quantity

Deliverable 2 Deadline:

COMPENSATION & PAYMENT

In consideration for the deliverables and license set forth herein, Brand/Client shall pay Agency/Creator as follows:

Total Fee Payment Schedule Kill Fee on Termination

USAGE RIGHTS & INTELLECTUAL PROPERTY

Agency/Creator hereby grants Brand/Client the following license to use Portfolio items and newly created Deliverables, subject to the limitations below. The parties agree that ownership of pre-existing materials and third-party materials remains with the original owner unless expressly assigned in writing.

License Grant (select applicable)

Non-exclusive license Exclusive license (if selected, specify territory and compensation below)

Territory & Duration

License Term Start:

License Term End:

Permitted Uses Sublicensing & Assignment

Brand/Client may sublicense portfolio items for marketing and promotional uses Sublicensing not permitted without prior written consent

FTC DISCLOSURE & COMPLIANCE

Agency/Creator warrants that any promotional content derived from the Portfolio or created under this Agreement will include clear and conspicuous disclosures of the commercial relationship as required by applicable consumer protection and advertising laws. Agency/Creator agrees to maintain records demonstrating compliance and to provide evidence to Brand/Client upon request.

Agency/Creator confirms disclosure compliance: I certify that required disclosures will be included in relevant placements and posts.

EXCLUSIVITY

If Brand/Client requires exclusivity, the parties must specify the scope and compensation. Absent a written exclusivity election, Agency/Creator retains the right to publish or license portfolio materials to other parties.

Exclusivity Election

Exclusivity elected — specify scope and fee below No exclusivity

If elected, exclusivity scope & fee

TERMINATION

Either party may terminate this Agreement for material breach after providing written notice and a cure period. Termination shall not relieve Brand/Client of payment obligations for services rendered and for work in progress as set forth below.

Notice Period for Termination Kill Fee on Termination

REPRESENTATIONS, WARRANTIES & INDEMNITY

Each party represents and warrants that it has the right and authority to enter into this Agreement. Agency/Creator represents that Portfolio items and Deliverables are original or properly licensed and do not infringe third-party rights. Agency/Creator shall indemnify and hold harmless Brand/Client from claims arising out of infringement, except to the extent caused by Brand/Client's unauthorized modifications or uses outside the License Grant.

Agency/Creator warranty confirmation: I warrant that I own or have rights to license the listed materials.

LIMITATION OF LIABILITY & GOVERNING LAW

Except for indemnity obligations or willful misconduct, neither party's aggregate liability arising out of or related to this Agreement shall exceed the total fees paid to Agency/Creator under this Agreement. This Agreement shall be governed by the laws of the state specified below.

Governing Law — State

CONFIDENTIALITY

Each party shall treat non-public information disclosed in connection with the Portfolio and Campaign as confidential and shall not disclose such information except as required by law or with the prior written consent of the disclosing party. Confidential information does not include information that is or becomes publicly known through no breach by the receiving party.

ACKNOWLEDGMENTS

By signing below, the parties acknowledge that they have read and agree to the terms above, that the Portfolio items listed are accurate to the best of Agency/Creator's knowledge, and that Brand/Client's use of the Portfolio will be limited to the uses and license described in this Agreement unless otherwise agreed in writing.

Confirmation of portfolio accuracy: Agency/Creator affirms that the listed publications are authentic and free of undisclosed encumbrances.

Brand / Client — Printed Name:

By:

Date:

Agency / Creator — Printed Name:

By:

Date:

What a Marketing Publication Portfolio Is and Why It Exists

A Marketing Publication Portfolio is a consolidated record of marketing assets, approvals, and distribution plans used by organizations to document published materials and promotional campaigns. It typically includes final artwork, copy approvals, version history, usage licenses, target audiences, media schedules, and distribution logs. The portfolio supports internal governance, legal review, and auditability by preserving decisions, sign-offs, and metadata tied to each publication. For regulated industries it can also demonstrate compliance with industry rules, consent requirements, or advertising standards, and it serves as an evidentiary record for disputes or post-campaign analysis.

Why maintaining a Marketing Publication Portfolio matters

A clear portfolio reduces legal and brand risk by centralizing approvals, tracking versions, and documenting third-party licenses. It streamlines review cycles and makes it easier to demonstrate compliance with industry rules such as advertising law or health privacy when applicable.

Who typically prepares and uses this portfolio

The portfolio supports internal decision-making and provides an auditable trail for post-release review or regulatory inquiries.

Marketing teams managing campaigns, creative assets, and distribution schedules for consistent brand execution.
Legal and compliance reviewers who verify claims, licensing, and regulatory language prior to release.
External agencies and contractors submitting assets and approvals for centralized recordkeeping and audit.

Essential components of a professional Marketing Publication Portfolio

A complete portfolio groups assets, approvals, metadata, distribution records, legal clearances, and version history so stakeholders can find and verify every published item quickly.

Final Assets

High-resolution files and production masters for each publication, clearly labeled with file type, dimensions, and color profile for reuse and archival retrieval.

Approval Log

Signed or time-stamped approvals showing who authorized each piece, role-based approver names, dates, and explicit scope of approval for legal defensibility.

Version History

Chronological record of revisions, editor notes, and comparative versions so teams can trace changes and restore prior iterations when needed.

Licenses & Rights

Documentation of third-party licenses, model releases, and usage terms with expiration dates and territorial or media restrictions clearly recorded.

Distribution Plan

Channel-by-channel schedule, audience targeting, and ad placements showing when and where materials were published and whether paid or organic.

Compliance Notes

Industry-specific checklists, required disclosures, or privacy consents attached to each item to demonstrate adherence to rules and policies.

Step-by-step: assemble and finalize the portfolio

Follow a consistent sequence to collect assets, verify rights, secure approvals, and record distribution details for each publication.

01

Collect Assets: Gather final files and source materials.
02

Verify Rights: Confirm licenses and releases are in place.
03

Obtain Approvals: Capture sign-offs with dates and roles.
04

Log Distribution: Record channels, dates, and any paid placements.

Where the completed portfolio is sent and stored

Define a single authoritative destination for the portfolio so teams and auditors know where to retrieve final records and supporting documentation.

Central Repository: Primary archival location for master records.
Legal Team: Copies delivered for compliance review.
Marketing Ops: Operational copy for campaign analytics.
External Auditors: Access provided under controlled permissions.

Technical considerations for digital completion and signing

Ensure the chosen system can export an audit trail, retain attachments, and meet any industry compliance needs such as HIPAA or recordkeeping rules.

File formats: PDF, DOCX, and high-resolution image support.
Integrations: Connectors for Google Workspace, Microsoft 365, and NetSuite.
Authentication: Email, SMS code, or stronger MFA options.

Configuring a reproducible approval workflow

Standardize workflow fields and routing to reduce variability and ensure each publication follows the same review path.

Field	Configuration
Signature Authentication	Email link, SMS code, or stronger MFA
Conditional Fields	Show fields based on role or channel
Bulk Send Settings	Enable batch approvals for large distributions
Storage Destination	Specify repository and folder path

eSignature vendor comparison for signing approvals

Compare basic pricing and key capabilities relevant when choosing an eSignature provider for portfolio approvals, with signNow listed first per platform rules.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Security and compliance highlights for portfolio records

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

Certifications: SOC 2 Type II, ISO 27001, PCI DSS

HIPAA Support: BAA required for protected health information

eSignature Law: Complies with ESIGN and UETA standards

Accessibility: WCAG 2.0 Level AA compatible

Audit Trail: Timestamps, IPs, and action history

Primary risks from incomplete or incorrect portfolios

Contract Disputes: Missing approvals can nullify obligations

Regulatory Fines: Noncompliance may trigger enforcement actions

Copyright Claims: Unlicensed use risks infringement suits

HIPAA Violations: Improper PHI handling can incur penalties

Reputational Harm: Erroneous claims undermine brand trust

Operational Delay: Incomplete records slow audits and renewals

Common preparation mistakes to avoid

Failing to attach final high-resolution files leads to inconsistent reproductions and ad rework across channels.
Recording informal approvals (email threads without signature) weakens the audit trail and complicates legal validation.
Neglecting to document license scope and expiration can result in unauthorized distribution or takedown requests.
Using inconsistent naming conventions makes it difficult to locate prior versions during dispute resolution or re-use.

Real-world examples of portfolio use

These short examples show how organizations document approvals and distribution to improve compliance and speed.

Optica Ventures (COO Brian Fitzgibbons)

The team centralized final assets and approvals to a single repository for campaign consistency.

This reduced duplicate versions across channels.
As a result, stakeholders reported faster retrieval of final files and fewer creative rework cycles, enabling predictable publishing and clearer accountability during internal and external reviews.

Martin Properties (Founder Tim Martin)

All marketing collateral was stored with signed approvals and distribution logs prior to release.

This ensured traceability for property listings.
The company avoided disputes over listing claims by having explicit approvals, preserved audit trails for consumer inquiries, and streamlined agent sign-off workflows across multiple offices.

Frequently asked questions about preparing and signing a portfolio

Answers address common legal, technical, and operational questions encountered when assembling and electronically signing a Marketing Publication Portfolio.

Need help? Contact support

Are electronic signatures legally binding?
Yes. Electronic signatures are legally recognized under the ESIGN Act (15 U.S.C. §7001) and by UETA in most states when intent, consent, attribution, and record retention are present.
When is a consumer disclosure required?
Consumer-facing records require ESIGN disclosures per 15 U.S.C. §7001(c): disclose the right to paper, confirm accessibility, and explain how to withdraw consent.
Do I need notarization for portfolio approvals?
Not usually for marketing approvals; notarization is only necessary when a state or specific contract requires it or when a document serves as an acknowledged legal instrument.
How long must I keep signed portfolio records?
Retention depends on applicable rules: IRS records three years (IRC §6501(a)), HIPAA six years (45 CFR §164.530(j)), or longer per state law or industry regulation.
What if an approver changes their name or role?
Maintain historical approvals with recorded name, title, and date. If identity differs, include verifying documentation to preserve attribution and mitigate disputes.
How should I handle PHI in marketing materials?
Avoid using PHI in marketing. If PHI is present, ensure HIPAA-compliant handling, a Business Associate Agreement, and appropriate patient authorization per HIPAA rules.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now